50 related articles for article (PubMed ID: 37460749)
1. Clinicopathologic analysis of nodal T-follicular helper cell lymphomas, a multicenter retrospective study from China.
Ma S; Li S; Zuo X; Li W; Wang L; Liu W; Wang Z; Sang W; Wang Y; Zhang X; Zhang M
Front Immunol; 2024; 15():1371534. PubMed ID: 38601148
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcome of peripheral T-cell lymphomas: Ten-year follow-up of the International Prospective T-cell Project.
Civallero M; Schroers-Martin JG; Horwitz S; Manni M; Stepanishyna Y; Cabrera ME; Vose J; Spina M; Hitz F; Nagler A; Montoto S; Chiattone C; Skrypets T; Perez Saenz MA; Priolo G; Luminari S; Lymboussaki A; Pavlovsky A; Marino D; Liberati M; Trotman J; Mannina D; Federico M; Advani R
Br J Haematol; 2024 Mar; ():. PubMed ID: 38532575
[TBL] [Abstract][Full Text] [Related]
3. Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification.
López-Guillermo A; Cid J; Salar A; López A; Montalbán C; Castrillo JM; González M; Ribera JM; Brunet S; García-Conde J; Fernández de Sevilla A; Bosch F; Montserrat E
Ann Oncol; 1998 Aug; 9(8):849-55. PubMed ID: 9789607
[TBL] [Abstract][Full Text] [Related]
4. Prognostic markers in peripheral T-cell lymphoma.
Piccaluga PP; Agostinelli C; Gazzola A; Mannu C; Bacci F; Sabattini E; Pileri SA
Curr Hematol Malig Rep; 2010 Oct; 5(4):222-8. PubMed ID: 20690003
[TBL] [Abstract][Full Text] [Related]
5. Low T3 syndrome as a predictor of poor prognosis in peripheral T-cell lymphomas.
Li W; Gao R; Wang W; Tang J; Yin H; Wu J; Liang J; Li Y; Wang L; Li J; Shen H; Xu W
Clin Transl Oncol; 2024 Mar; 26(3):613-622. PubMed ID: 37460749
[TBL] [Abstract][Full Text] [Related]
6. Ukraine Data on Prognostic Factors and Treatment Outcomes in Patients with Peripheral T-Cell Lymphomas.
Skrypets T; Novosad O; Pastushenko Y; Gorbach O; Kriachok I
Klin Onkol; 2019; 32(6):436-444. PubMed ID: 31842562
[TBL] [Abstract][Full Text] [Related]
7. 25-Hydroxy vitamin D deficiency is an inferior predictor of peripheral T-cell lymphomas.
Shen HR; Tang J; Li WY; Liang JH; Li Y; Wu JZ; Wang L; Li JY; Gao R; Yin H; Xu W
Ann Hematol; 2024 Feb; 103(2):565-574. PubMed ID: 37951853
[TBL] [Abstract][Full Text] [Related]
8. Low T3 syndrome is a strong prognostic predictor in diffuse large B cell lymphoma.
Gao R; Liang JH; Wang L; Zhu HY; Wu W; Wu JZ; Xia Y; Cao L; Fan L; Yang T; Li JY; Xu W
Br J Haematol; 2017 Apr; 177(1):95-105. PubMed ID: 28146267
[TBL] [Abstract][Full Text] [Related]
9. Low T3 syndrome as a predictor of poor outcomes in patients with follicular lymphoma.
Xue LG; Shen HR; Gao R; Du KX; Xing TY; Wang WT; Wang L; Li JY; Liang JH; Xu W
Ann Hematol; 2023 Apr; 102(4):851-862. PubMed ID: 36735075
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic significance of NCCN-International Prognostic Index (NCCN-IPI) for patients with peripheral T-cell lymphoma treated with CHOP-based chemotherapy].
Zhang MC; Xu PP; Zhong HJ; Zhao X; Zhao WL; Cheng S
Zhonghua Xue Ye Xue Za Zhi; 2017 Sep; 38(9):772-777. PubMed ID: 29081194
[No Abstract] [Full Text] [Related]
11. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.
Alaggio R; Amador C; Anagnostopoulos I; Attygalle AD; Araujo IBO; Berti E; Bhagat G; Borges AM; Boyer D; Calaminici M; Chadburn A; Chan JKC; Cheuk W; Chng WJ; Choi JK; Chuang SS; Coupland SE; Czader M; Dave SS; de Jong D; Du MQ; Elenitoba-Johnson KS; Ferry J; Geyer J; Gratzinger D; Guitart J; Gujral S; Harris M; Harrison CJ; Hartmann S; Hochhaus A; Jansen PM; Karube K; Kempf W; Khoury J; Kimura H; Klapper W; Kovach AE; Kumar S; Lazar AJ; Lazzi S; Leoncini L; Leung N; Leventaki V; Li XQ; Lim MS; Liu WP; Louissaint A; Marcogliese A; Medeiros LJ; Michal M; Miranda RN; Mitteldorf C; Montes-Moreno S; Morice W; Nardi V; Naresh KN; Natkunam Y; Ng SB; Oschlies I; Ott G; Parrens M; Pulitzer M; Rajkumar SV; Rawstron AC; Rech K; Rosenwald A; Said J; Sarkozy C; Sayed S; Saygin C; Schuh A; Sewell W; Siebert R; Sohani AR; Tooze R; Traverse-Glehen A; Vega F; Vergier B; Wechalekar AD; Wood B; Xerri L; Xiao W
Leukemia; 2022 Jul; 36(7):1720-1748. PubMed ID: 35732829
[TBL] [Abstract][Full Text] [Related]
12. Nonthyroidal Illness Syndrome: To Treat or Not to Treat? Have We Answered the Question? A Review of Metanalyses.
Sciacchitano S; Capalbo C; Napoli C; Anibaldi P; Salvati V; De Vitis C; Mancini R; Coluzzi F; Rocco M
Front Endocrinol (Lausanne); 2022; 13():850328. PubMed ID: 35620389
[TBL] [Abstract][Full Text] [Related]
13. Low free-T3 serum levels and prognosis of COVID-19: systematic review and meta-analysis.
Llamas M; Garo ML; Giovanella L
Clin Chem Lab Med; 2021 Nov; 59(12):1906-1913. PubMed ID: 34380183
[TBL] [Abstract][Full Text] [Related]
14. Gene signature and immune cell profiling by high-dimensional, single-cell analysis in COVID-19 patients, presenting Low T3 syndrome and coexistent hematological malignancies.
Sciacchitano S; De Vitis C; D'Ascanio M; Giovagnoli S; De Dominicis C; Laghi A; Anibaldi P; Petrucca A; Salerno G; Santino I; Amodeo R; Simmaco M; Napoli C; Tafuri A; Di Napoli A; Sacconi A; Salvati V; Ciliberto G; Fanciulli M; Piaggio G; de Latouliere L; Ricci A; Mancini R
J Transl Med; 2021 Apr; 19(1):139. PubMed ID: 33794925
[TBL] [Abstract][Full Text] [Related]
15. Association Between Low T3 Syndrome and Poor Prognosis in Adult Patients With Acute Myocarditis.
Zhao Y; Wang W; Zhang K; Tang YD
Front Endocrinol (Lausanne); 2021; 12():571765. PubMed ID: 33763025
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
